Stay updated on Johnson & Johnson Press Releases
Sign up to get notified when there's something new on the Johnson & Johnson Press Releases page.

Latest updates to the Johnson & Johnson Press Releases page
- Check2 days agoChange DetectedThe press-release feed adds late-October 2026 announcements, including results for investigational treatments for head and neck and prostate cancers, and removes several earlier Crohn’s disease and multiple myeloma releases. The displayed result count increases from 2,359 to 2,363.SummaryDifference7%

- Check9 days agoChange DetectedThe listing now features newer October 19–23, 2026 announcements on cancer and rheumatology research, atrial-fibrillation treatment data, surgical technology, and a new coronary IVL catheter. Several earlier financial and product-related releases have dropped off the listing, and the displayed result count changes from 2,352 to 2,358.SummaryDifference7%

- Check16 days agoChange DetectedThe listing adds recent October 2026 announcements on TALVEY and TREMFYA, Q3 earnings and guidance, and the quarterly dividend, while older September releases are no longer shown. The displayed search-result count rises from 2,346 to 2,352.SummaryDifference7%

- Check23 days agoChange DetectedThe latest listing now features October 9, 2026, ICOTYDE data reporting sustained two-year psoriasis treatment results. The September 14, 2026, release about oncology AI adoption is no longer listed, and the result count increased from 2,345 to 2,346.SummaryDifference2%

- Check30 days agoChange DetectedThe press-release list now includes newer announcements on ICOTYDE psoriasis data, women’s eye health and menopause, and IMAAVY outcomes in myasthenia gravis, while older releases have been removed. The displayed search-result total increased from 2,342 to 2,345.SummaryDifference7%

- Check37 days agoChange DetectedNew press release items dated September 25–21, 2026 were added to the press releases listing, including TREMFYA and CARVYKTI updates, TECVAYLI plus DARZALEX FASPRO analyses, CAPLYTA bipolar mania results, and related summaries. Older entries were removed and the total results count updated from 2,337 to 2,342.SummaryDifference7%

Stay in the know with updates to Johnson & Johnson Press Releases
Enter your email address, and we'll notify you when there's something new on the Johnson & Johnson Press Releases page.